|
HS Code |
386480 |
As an accredited 6-Bromo-4-Iodo-1H-Indazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-4-Iodo-1H-Indazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry often feels crowded with complicated names and stranger compounds, but once you step inside the world of indazoles, it all begins to make sense. In my years around synthesis labs and research teams, 6-Bromo-4-Iodo-1H-Indazole has popped up on my bench more than a few times. The moment researchers swap stories about the hurdles of heterocycle modification, this unique molecule always comes up. Not because it sits around as a wallpaper chemical either — its dual halogenation pattern on a core backbone delivers surprising possibilities that rarely go unnoticed.
Inside the 1H-indazole family, putting a bromine atom at the 6-position and an iodine at the 4-position might not seem revolutionary. With a molecular formula of C7H4BrIN2, this compound shows off a smart design. The indazole ring serves as a sturdy frame, commonly used in biological studies and medicinal chemistry. Add bromine and iodine, and you introduce new handles for further reactions — cross-coupling comes easy, and selectivity improves. That specific configuration gives researchers control they often crave in more basic indazoles. Some might wonder how added halogens make much of a difference. I’ve run reactions with less elaborate indazoles and watched as the outcomes turned unpredictable; every so often, a little extra functional group at the right spot turns a headache into a success story.
6-Bromo-4-Iodo-1H-Indazole offers a fine-tuned scaffold for those chasing specific targets in organic synthesis. A closer look at its performance level shows it brings high purity and stability to reactions that call for reliable starting materials. In industries where cost and outcome matter – like drug discovery or agricultural chemistry – such characteristics lead to less waste and fewer failed batches. I remember one project at a pharmaceutical lab where we chased down kinase inhibitors. Swapping a plain indazole for this doubly halogenated cousin opened pathways the plain version shut tight, delivering candidates our screens would have otherwise missed.
Researchers don’t pick this compound hoping for minor tweaks. Drug discovery and advanced material science both lean heavily on indazole cores, especially those loaded with useful groups at precise sites. Bromine and iodine make this molecule a natural fit for Suzuki-Miyaura and Sonogashira cross-couplings. If your work needs to add complexity or branch out from a sturdy core, this compound slips in nicely. On the bench, I’ve seen colleagues use this indazole in the assembly of small molecule libraries or as a key step in making potential pharmaceuticals. Its use goes far beyond theory — downstream products can include enzyme inhibitors, fluorescent probes, or advanced ligands for metal-catalyzed reactions. The reality on the floor is that you want building blocks that don’t stall progress, and 6-Bromo-4-Iodo-1H-Indazole consistently delivers.
The marketplace for building blocks gets crowded pretty quickly. Dozens of indazoles line shelves, many boasting single halogenation or unsubstituted rings. Someone looking just to fill space on a molecular grid might grab any old indazole. Yet, the combined presence of both bromine and iodine offers a toolkit that lets the chemist run different cross-coupling reactions from one molecule. With both options on board, you can set reaction order flexibly — avoid unwanted competition, steer clear of unwanted side-products, and experiment with several approaches in one workflow. That’s not a small shift if you’ve spent weeks debugging a tricky series.
If you’re choosing between building blocks, efficiency and adaptability trump generic options every time. I’ve worked jobs where cost pressures made us squeeze every bit of value from our stockroom. Bringing in a dual-halogenated indazole saved us time, solvents, and headaches trying to reroute failed syntheses. You don’t measure that value until you’re staring at a stubborn intermediate that won’t budge. Iodine’s higher reactivity balances with bromine’s more measured pace, and controlling which group reacts first helps streamline purification and minimize byproducts — a real benefit when you calculate lost time.
The real measure of any specialty molecule comes from its track record in actual studies, not just vendor marketing. Academic literature shows repeated interest in halogenated indazoles. In journals covering medicinal chemistry, one recurring theme keeps popping up: placing halogens alters biological activity, often improving specificity toward a target protein. Within kinase inhibitor development, changing just one group on an otherwise idle indazole produces striking shifts in potency or side effect profile. Trials with 6-Bromo-4-Iodo-1H-Indazole analogs have yielded promising leads, especially where dual reactivity paves short routes to complex scaffolds.
Sometimes it’s not the therapeutic activity but the versatility that makes the difference. In a joint industry-academic project I observed, teams worked to design labeled molecules for imaging studies. The combination of bromine and iodine let them introduce radiolabeled analogs without overhauling their initial syntheses. Those advances reduce design time, trimming months from the development cycle. That means researchers move from concept to actionable data with fewer hurdles. I watched as broad screening began with generic, less-decorated indazoles, but the labs that pivoted to the 6-bromo-4-iodo derivative found success faster and more often.
No tool solves everything. On paper, adding large halogens promises easy modification, but sometimes the real world chimes in with issues. One concern that has come up in different teams is the cost and sourcing difficulties, especially for high-purity batches. Purification brings its own struggles if the molecule contains impurities from the starting materials or byproducts from the synthesis steps. Another trouble spot: not every reaction with this indazole adapts seamlessly from its less-hindered relatives. Over the years, I’ve seen trial runs where sluggish reactivity slowed expected reaction rates, forcing late nights tweaking solvents and ligands until yields improved.
Beyond the bench, sustainability raises valid concerns. Two large halogens mean more weight and atomization in each molecule, which can impact waste treatment and environmental impact downstream. Regulatory landscapes grow stricter on halogenated waste, so the more efficiently a lab can use its indazole core, the less likely it is to run afoul of compliance audits or ballooning disposal costs.
Boosting access and practicality starts upstream, right at the point of synthesis. Suppliers increasingly recognize the demand for cleaner, higher-yield production methods to generate pure 6-Bromo-4-Iodo-1H-Indazole. Switching to greener reaction conditions, such as milder bases and recyclable solvents, helps reduce unwanted byproducts. I’ve seen improvements as labs adopted palladium-catalyzed halogenation techniques, which cut down on both energy use and purification headaches. That shift lowered costs in the long run, since less material gets lost in cleanup and more product finds its way into reactions instead of waste barrels.
From a planning perspective, labs that map their synthetic sequence around this molecule’s dual functionalization gain a step up. Smart scheduling — pairing reactivity with purification tactics — reduces time spent chasing minor impurities. Carefully choosing which halogen to exploit first, depending on the catalyst and reaction conditions, improves selectivity. Talking with process chemists outside my own research group led me to rethink when and how to introduce halogenated intermediates. We found that a little foresight at the design stage pays off in the long run, especially as regulatory scrutiny grows around chemical sourcing and disposal.
A laboratory choosing specialty chemicals faces two big responsibilities: ensuring product safety and protecting both workers and the environment. High standards for purity and traceability reduce risks from residual solvents or unexpected heavy metals. This is especially true for compounds like 6-Bromo-4-Iodo-1H-Indazole, which may end up in early-stage drug pipelines. I’ve watched safety teams grow increasingly strict about documentation, especially as regulators tighten rules on halogenated intermediates. Companies that keep robust internal audits and transparent sourcing enjoy smoother collaboration with partners and speedier approvals — both good for science and safer for everyone working along the supply chain.
Labs and companies that invest in third-party testing, even when regulations don’t require it, see lower rates of problematic batches or recalls. Responsible sourcing doesn’t just prevent a headline-grabbing incident; it keeps research robust and moves projects along faster. In my experience, the costs associated with high-quality specialty reagents get paid back by slashed troubleshooting and improved reproducibility. Having run both budget-tight and well-funded projects, the difference in lab morale and productivity stands out the moment issues with raw materials stop hogging the discussion at weekly progress meetings.
A molecule doesn’t earn its place in a chemist’s toolkit just by existing in a catalog; it’s the repeatable, reliable outcome that matters. In practical terms, that means monitoring every step of the supply and handling process. Vendors who take their time with batch verification, full spectral analysis, and stability checks help prevent headaches on the receiving end. Some of the most respected labs I’ve partnered with keep a strict log for each key compound, like 6-Bromo-4-Iodo-1H-Indazole, linking spectral certificates right into their inventory system. If a batch ever turns up off-spec, that traceability makes it simple to rerun validation and avoid surprises mid-project.
It’s also worth noting how small improvements build up over hundreds of reactions. The extra attention to detail when storing — keeping light out, limiting air exposure, and using appropriate vials — adds life and reliability to each bottle. That sort of careful practice avoids disasters, especially if the indazole ends up as a precursor in the synthesis of bioactives or diagnostic tools.
As research directions shift toward ever more specialized targets, the pressure grows for building blocks that balance adaptability, reliability, and responsible sourcing. It’s not enough just to have a rare reagent on the shelf — scientists look for compounds that solve actual problems and fit seamlessly into broader workflows. Among indazoles, 6-Bromo-4-Iodo-1H-Indazole sits at a sweet spot: specialized enough to open otherwise-blocked synthetic doors, but reliable and well-documented for everyday bench work.
Looking ahead, labs will keep refining how they handle, store, and use such dual-halogenated tools. Some already partner with suppliers to tweak packaging for longer shelf life or request smaller batch runs to cut down on waste. I’ve seen demand rise for in-depth user guides and flowcharts that show which catalyst, solvent, or temperature gives the highest yield with this indazole. Online communities swap data between academic and industrial scientists, speeding the troubleshooting process. As a result, the transition from synthetic plan to usable material only grows smoother.
There’s an old saw in chemistry that a reaction is only as good as its starting material. My own experience keeps proving this true. 6-Bromo-4-Iodo-1H-Indazole, with its judicious addition of bromine and iodine, brings a blend of predictability and opportunity to a wide range of projects — a quiet workhorse in the toolkit. As the pressure to innovate grows, so does the importance of thoughtful sourcing, robust documentation, and attentive process control. The labs and companies that embrace this approach find themselves wasting less time, generating less waste, and moving more quickly from big ideas to concrete results.
Anyone working at the bench — or overseeing folks who do — knows the value of a reliable tool. This indazole, sturdy and versatile, keeps opening new creative routes. As the next wave of challenges rolls in, having compounds like this at your disposal just makes research a little brighter and the science a lot smoother.